양극성 장애 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Bipolar Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1508419
리서치사:Transparency Market Research
발행일:2024년 05월
페이지 정보:영문 143 Pages
라이선스 & 가격 (부가세 별도)
한글목차
이 보고서는 2024-2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 세계 양극성 장애 치료 시장을 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018-2034년까지의 세계 양극성 장애 치료 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 양극성 장애 치료 시장의 연평균 복합 성장률(CAGR%)도 제시합니다.
이 보고서는 광범위한 조사 끝에 작성되었으며, 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 양극성 장애 치료 시장을 이해했습니다, 양극성 장애 치료 시장을 이해했습니다.
시장 현황
2023년 시장 규모
51억 달러
2034년 시장 규모
92억 달러
CAGR
5.4%
이 보고서는 세계 양극성 장애 치료 시장의 경쟁 환경을 조사했습니다. 세계 양극성 장애 치료 시장에서 사업을 전개하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 양극성 장애 치료 시장의 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 치료 유형별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 치료 유형별, 2020-2034년
약물치료
심리치료
전기 경련 요법(ECT)
경두개 자기 자극(TMS)
기타(입원 등)
시장 매력 : 치료 유형별
제7장 세계 시장 분석과 예측 : 약제 클래스별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 약제 클래스별, 2020-2034년
기분 안정제
항정신병제
항우울제
항불안제
기타(항간질약 등)
시장 매력 : 약제 클래스별
제8장 세계 시장 분석과 예측 : 조울증 유형별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 조울증 유형별, 2020-2034년
조울증 I형 장애
조울증 II형 장애
주기성 장애
기타(특정 및 비특정 조울증 및 관련 장애 등)
시장 매력 : 조울증 유형별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원
전문 클리닉
정신건강 센터
외래수술센터(ASC)
시장 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 계층·규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Otsuka Pharmaceutical Co., Ltd.
AstraZeneca plc
GSK plc
Pfizer Inc.
Eli Lilly and Company
Johnson & Johnson
AbbVie Inc.
Novartis AG
Allergan plc
Lundbeck A/S
LSH
영문 목차
영문목차
Bipolar Disorder Treatment Market - Scope of Report
TMR's report on the global bipolar disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bipolar disorder treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bipolar disorder treatment market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bipolar disorder treatment market.
Market Snapshot
Market Value in 2023
US$ 5.1 Bn
Market Value in 2034
US$ 9.2 Bn
CAGR
5.4%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bipolar disorder treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bipolar disorder treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bipolar disorder treatment market.
The report delves into the competitive landscape of the global bipolar disorder treatment market. Key players operating in the global bipolar disorder treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bipolar disorder treatment market profiled in this report.
Key Questions Answered in Global bipolar disorder treatment Market Report:
What is the sales/revenue generated by bipolar disorder treatment across all regions during the forecast period?
What are the opportunities in the global bipolar disorder treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Bipolar Disorder Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global bipolar disorder treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global bipolar disorder treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bipolar disorder treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bipolar Disorder Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bipolar Disorder Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Treatment
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Treatment, 2020-2034
6.3.1. Pharmacotherapy
6.3.2. Psychotherapy
6.3.3. Electroconvulsive Therapy (ECT)
6.3.4. Transcranial Magnetic Stimulation (TMS)
6.3.5. Others (Hospitalization, etc.)
6.4. Market Attractiveness, by Type of Treatment
7. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Drug Class
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Class, 2020-2034
7.3.1. Mood Stabilizers
7.3.2. Antipsychotics
7.3.3. Anti-depressants
7.3.4. Antianxiety Drugs
7.3.5. Others (Anticonvulsants, etc.)
7.4. Market Attractiveness, by Drug Class
8. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Bipolar Disorder
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
8.3.1. Bipolar I Disorder
8.3.2. Bipolar II Disorder
8.3.3. Cyclothymic Disorder
8.3.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
8.4. Market Attractiveness, by Type of Bipolar Disorder
9. Global Bipolar Disorder Treatment Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Mental Health Centers
9.3.4. Ambulatory Surgical Centers
9.4. Market Attractiveness, by End-user
10. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Bipolar Disorder Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type of Treatment, 2020-2034
11.2.1. Pharmacotherapy
11.2.2. Psychotherapy
11.2.3. Electroconvulsive Therapy (ECT)
11.2.4. Transcranial Magnetic Stimulation (TMS)
11.2.5. Others (Hospitalization, etc.)
11.3. Market Attractiveness, by Type of Treatment
11.4. Market Value Forecast, by Drug Class, 2020-2034
11.4.1. Mood Stabilizers
11.4.2. Antipsychotics
11.4.3. Anti-depressants
11.4.4. Antianxiety Drugs
11.4.5. Others (Anticonvulsants, etc.)
11.5. Market Attractiveness, by Drug Class
11.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
11.6.1. Bipolar I Disorder
11.6.2. Bipolar II Disorder
11.6.3. Cyclothymic Disorder
11.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
11.7. Market Attractiveness, by Type of Bipolar Disorder
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Mental Health Centers
11.8.4. Ambulatory Surgical Centers
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Type of Treatment
11.11.2. By Drug Class
11.11.3. By Type of Bipolar Disorder
11.11.4. By End-user
11.11.5. By Country
12. Europe Bipolar Disorder Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type of Treatment, 2020-2034
12.2.1. Pharmacotherapy
12.2.2. Psychotherapy
12.2.3. Electroconvulsive Therapy (ECT)
12.2.4. Transcranial Magnetic Stimulation (TMS)
12.2.5. Others (Hospitalization, etc.)
12.3. Market Attractiveness, by Type of Treatment
12.4. Market Value Forecast, by Drug Class, 2020-2034
12.4.1. Mood Stabilizers
12.4.2. Antipsychotics
12.4.3. Anti-depressants
12.4.4. Antianxiety Drugs
12.4.5. Others (Anticonvulsants, etc.)
12.5. Market Attractiveness, by Drug Class
12.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
12.6.1. Bipolar I Disorder
12.6.2. Bipolar II Disorder
12.6.3. Cyclothymic Disorder
12.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
12.7. Market Attractiveness, by Type of Bipolar Disorder
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Specialty Clinics
12.8.3. Mental Health Centers
12.8.4. Ambulatory Surgical Centers
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Type of Treatment
12.11.2. By Drug Class
12.11.3. By Type of Bipolar Disorder
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Bipolar Disorder Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type of Treatment, 2020-2034
13.2.1. Pharmacotherapy
13.2.2. Psychotherapy
13.2.3. Electroconvulsive Therapy (ECT)
13.2.4. Transcranial Magnetic Stimulation (TMS)
13.2.5. Others (Hospitalization, etc.)
13.3. Market Attractiveness, by Type of Treatment
13.4. Market Value Forecast, by Drug Class, 2020-2034
13.4.1. Mood Stabilizers
13.4.2. Antipsychotics
13.4.3. Anti-depressants
13.4.4. Antianxiety Drugs
13.4.5. Others (Anticonvulsants, etc.)
13.5. Market Attractiveness, by Drug Class
13.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
13.6.1. Bipolar I Disorder
13.6.2. Bipolar II Disorder
13.6.3. Cyclothymic Disorder
13.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
13.7. Market Attractiveness, by Type of Bipolar Disorder
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Specialty Clinics
13.8.3. Mental Health Centers
13.8.4. Ambulatory Surgical Centers
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Type of Treatment
13.11.2. By Drug Class
13.11.3. By Type of Bipolar Disorder
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Bipolar Disorder Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type of Treatment, 2020-2034
14.2.1. Pharmacotherapy
14.2.2. Psychotherapy
14.2.3. Electroconvulsive Therapy (ECT)
14.2.4. Transcranial Magnetic Stimulation (TMS)
14.2.5. Others (Hospitalization, etc.)
14.3. Market Attractiveness, by Type of Treatment
14.4. Market Value Forecast, by Drug Class, 2020-2034
14.4.1. Mood Stabilizers
14.4.2. Antipsychotics
14.4.3. Anti-depressants
14.4.4. Antianxiety Drugs
14.4.5. Others (Anticonvulsants, etc.)
14.5. Market Attractiveness, by Drug Class
14.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
14.6.1. Bipolar I Disorder
14.6.2. Bipolar II Disorder
14.6.3. Cyclothymic Disorder
14.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
14.7. Market Attractiveness, by Type of Bipolar Disorder
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Specialty Clinics
14.8.3. Mental Health Centers
14.8.4. Ambulatory Surgical Centers
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Type of Treatment
14.11.2. By Drug Class
14.11.3. By Type of Bipolar Disorder
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Bipolar Disorder Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type of Treatment, 2020-2034
15.2.1. Pharmacotherapy
15.2.2. Psychotherapy
15.2.3. Electroconvulsive Therapy (ECT)
15.2.4. Transcranial Magnetic Stimulation (TMS)
15.2.5. Others (Hospitalization, etc.)
15.3. Market Attractiveness, by Type of Treatment
15.4. Market Value Forecast, by Drug Class, 2020-2034
15.4.1. Mood Stabilizers
15.4.2. Antipsychotics
15.4.3. Anti-depressants
15.4.4. Antianxiety Drugs
15.4.5. Others (Anticonvulsants, etc.)
15.5. Market Attractiveness, by Drug Class
15.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
15.6.1. Bipolar I Disorder
15.6.2. Bipolar II Disorder
15.6.3. Cyclothymic Disorder
15.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
15.7. Market Attractiveness, by Type of Bipolar Disorder
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Specialty Clinics
15.8.3. Mental Health Centers
15.8.4. Ambulatory Surgical Centers
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Type of Treatment
15.11.2. By Drug Class
15.11.3. By Type of Bipolar Disorder
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Otsuka Pharmaceutical Co., Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. AstraZeneca plc
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. GSK plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Pfizer Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Eli Lilly and Company
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Johnson & Johnson
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. AbbVie Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Novartis AG
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Allergan plc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Lundbeck A/S
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
